Hodis E, Watson IR, Kryukov GV, Arold ST, Imielinski M, Theurillat JP, Nickerson E, Auclair D, Li L, Place C, Dicara D, Ramos AH, Lawrence MS, Cibulskis K, Sivachenko A, Voet D, Saksena G, Stransky N, Onofrio RC, Winckler W, Ardlie K, Wagle N, Wargo J, chong K, Morton DL, Stemk-Hale K, Chen G, Noble M, Meyrson M, Ladbury JE, Davies MA, Gershenwald JE, Wagner Sn, Hoon DSB, Shadendorf D, Lander ES, Gabriel SBl, Getz G, Garraway LA, Chin L
Patients with untreated narrow anterior chamber angles are at risk for angle closure glaucoma[4]because of increased eye pressure
#GRAPPA2026 #Dermatology #PsoriaticArthritis #Psoriasis #MedicalResearch #Lisbon To view or add a comment, sign in #IPCJrCouncilors Dra
SO is projected to affect up to 200 million individuals over the next 35 years, underscoring its potential as an increasingly important public health issue [4]
Kurokawa R et al
[Accessed on 11 June 2026] Orforglipron, an oral small-molecule GLP-1 receptor agonist for obesity treatment (2025)